RXII - RXi Pharmaceuticals Corporation

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
No. of Analysts0001
Avg. Estimate000-2.14
Low Estimate000-2.14
High Estimate000-2.14
Year Ago EPS-3.4-6N/AN/A
Revenue EstimateCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
No. of Analysts1111
Avg. EstimateN/AN/AN/A80k
Low EstimateN/AN/AN/A80k
High EstimateN/AN/AN/A80k
Year Ago SalesN/AN/A19kN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History9/29/201612/30/20163/30/20176/29/2017
EPS Est.-3.4-2.3-1.1-1.1
EPS Actual-3.4-6-1.2-1.1
Difference0-3.7-0.10
Surprise %0.00%-160.90%-9.10%0.00%
EPS TrendCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
Current Estimate000-2.14
7 Days Ago-0.11-0.11-1.77-0.57
30 Days Ago-0.11-0.11-1.77-0.57
60 Days Ago-0.11-0.11-1.77-0.57
90 Days Ago-0.11-0.11-1.77-0.57
EPS RevisionsCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesRXIIIndustrySectorS&P 500
Current Qtr.N/AN/AN/A0.43
Next Qtr.N/AN/AN/A0.47
Current YearN/AN/AN/A0.22
Next YearN/AN/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A